Leawood, KS, United States of America

Douglas S McNair

This inventor holds 177 USPTO granted patents and 38 published patent applications, primarily in Clinical Decision Support (CPC class G16H10-60). Top assignees: Cerner Innovation, Inc., Cerner Corporation, Oracle International Corporation. Active years: 2004-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Douglas S McNair. Retrieved from https://idiyas.com/inventor/douglas-s-mcnair

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 177 

% Patents Active = 98.3

Average Co-Inventor Count = 1.2

ph-index = 21

Forward Citations = 1,618(Granted Patents)

Forward Citations (Not Self Cited) = 948(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Leawood, KS (US) (2004 - 2024)
  • Seattle, WA (US) (2020 - 2024)

Company Filing History:


Years Active: 2004-2026

Loading Chart...
Areas of Expertise:
Chronic Kidney Disease
Decision Support Tool
Mental Health Management
Natural Language Processing
Clinical Decision Making
Health Quality Credits
Risk Evaluation
Patient Monitoring
Health Outcome Surveillance
Addiction Relapse
Record Linkage
Physiologic Timeseries
177 patents (USPTO):Explore Patents

Title: Douglas S McNair: Innovating for a Better Future

Introduction:

Meet Douglas S McNair, an accomplished innovator hailing from Leawood, Kansas. With a diverse range of expertise and a remarkable track record in patent filings, McNair has made significant contributions to the fields of machine learning and assistive technology. In this article, we will explore some of his latest patents, highlight his notable career achievements, and delve into his collaborations with fellow industry professionals.

Latest Patents:

McNair's latest patents showcase his commitment to advancing technology in two distinct domains:

1. Classifier Apparatus with Decision Support Tool:

This patent introduces an improved classifier apparatus aimed at enhancing the accuracy of classification technology. By applying clustering techniques to the variables involved in the classification task, McNair improves the interrelationship analysis. The use of a convolutional transformation helps to reduce dimensionality and minimize signal-to-noise ratio. Additionally, a deep learning neural network method generates an improved classification model, facilitating the development of a decision support tool. Notably, this patent has an application in detecting the risk of venous thrombosis and venous thromboembolism in patients.

2. Tool for Assisting People with Speech Disorders:

In this patent, McNair presents various tools designed to aid individuals with speech disabilities. By leveraging automatic speech recognition (ASR) systems, these technologies ascertain and enhance the accuracy of recognizing utterances from individuals with impaired speech conditions. The patent outlines a process that involves analyzing digitized audio information to determine candidate words matching the speaker's utterance. A finite state machine model helps identify the corresponding concepts, which are represented through pictograms. The speaker can then select the pictogram that best conveys their intended meaning, with the system responding accordingly.

Career Highlights:

Throughout his career, McNair has worked with Cerner Innovation, Inc., a leading company in healthcare technology. His invaluable contributions have driven the advancement of machine learning algorithms and decision support tools within the healthcare industry. McNair's dedication to improving patient outcomes through innovative solutions has earned him widespread recognition.

Collaborations:

Collaboration plays a vital role in achieving groundbreaking innovations, and McNair has had the opportunity to work with talented individuals. Two notable colleagues include John Christopher Murrish and Kanakasabha Kailasam. Together, they have synergized their skills and expertise to push the boundaries of machine learning and assistive technologies. Their collaborative efforts have resulted in patentable inventions that have the potential to transform industries and improve the lives of people around the world.

Conclusion:

Douglas S McNair's impressive portfolio of 129 patents is a testament to his dedication, ingenuity, and passion for advancing technology. Through his inventions, McNair has made significant contributions to the realms of classification apparatus and assistive technology for speech disorders. His collaboration with esteemed colleagues and his noteworthy career with Cerner Innovation, Inc. further solidify his standing as an innovator of great impact. McNair's work continues to pave the way for a brighter and more inclusive future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…